Results 11 to 20 of about 45,389 (224)

CAQ Corner: Basic concepts of transplant immunology

open access: yes, 2022
Liver Transplantation, EarlyView.
Amanda Cheung, Josh Levitsky
wiley   +1 more source

Design and rationale of a multi-center, pragmatic, open-label randomized trial of antimicrobial therapy - the study of clinical efficacy of antimicrobial therapy strategy using pragmatic design in Idiopathic Pulmonary Fibrosis (CleanUP-IPF) clinical trial [PDF]

open access: yes, 2020
Compelling data have linked disease progression in patients with idiopathic pulmonary fibrosis (IPF) with lung dysbiosis and the resulting dysregulated local and systemic immune response.
A Mishra   +43 more
core   +1 more source

Daptomycin‐induced hyperkalemia: A case report and brief description of mechanism

open access: yesClinical Case Reports, 2023
Key Clinical Message Daptomycin causes serious side effects like rhabdomyolysis at high doses. At lower doses it can cause isolated hyperkalemia without frank rhabdomyolysis.
Praveen Errabelli   +2 more
doaj   +1 more source

Recurrent Hyperkalemia During General Anesthesia in a Dog

open access: yesFrontiers in Veterinary Science, 2020
Objective: To describe the development of recurrent hyperkalemia in a dog that underwent general anesthesia at two different hospitals within a month. The definitive underlying cause of the hyperkalemia remains unknown.Case summary: A 11 year-old male ...
Carissa W. Tong   +2 more
doaj   +1 more source

Postoperative hyperkalemia

open access: yesEuropean Journal of Internal Medicine, 2015
Hyperkalemia occurs frequently in hospitalized patients and is of particular concern for those who have undergone surgery, with postoperative care provided by clinicians of many disciplines. This review describes the normal physiology and how multiple perioperative factors can disrupt potassium homeostasis and lead to severe elevations in plasma ...
Taha, Ayach   +4 more
openaire   +3 more sources

Predictors for repeated hyperkalemia and potassium trajectories in high-risk patients - A population-based cohort study.

open access: yesPLoS ONE, 2019
Understanding predictors and trajectories of increased potassium may inform testing and treatment of hyperkalemia. We examined predictors for repeated hyperkalemia among patients after first-time renin angiotensin system inhibitor (RASi) prescription ...
Kasper Adelborg   +5 more
doaj   +1 more source

Serum potassium levels of patients on angiotensin converting enzyme inhibitors – A cross-sectional study

open access: yesNational Journal of Physiology, Pharmacy and Pharmacology, 2020
Background: Angiotensin-converting enzyme (ACE) inhibitors are commonly used in clinical practice to treat hypertension. Hyperkalemia develops in approximately 10% of outpatients within a year of prescription of these drugs.
Vishnupriya Ramakrishnan   +1 more
doaj   +1 more source

ECG alterations suggestive of hyperkalemia in normokalemic versus hyperkalemic patients

open access: yesBMC Emergency Medicine, 2019
Background In periarrest situations and during resuscitation it is essential to rule out reversible causes. Hyperkalemia is one of the most common, reversible causes of periarrest situations.
Csaba Varga   +9 more
doaj   +1 more source

Hyperkalemia in chronic peritoneal dialysis patients

open access: yesRenal Failure, 2022
Background. Chronic peritoneal dialysis (PD) patients often develop hypokalemia but less commonly hyperkalemia. Methods. We explored incidence and mechanisms of hyperkalemia in 779 serum samples from 33 patients on PD for 1 − 59 months.
Andrew B. Elliott   +2 more
doaj   +1 more source

Hyperkalemia-induced brugada phenocopy: A rare electrocardiogram manifestation

open access: yesJournal of the Practice of Cardiovascular Sciences, 2022
Hyperkalemia-induced Brugada ECG pattern is rare. Although the association of hyperkalemia with Brugada pattern is a known entity, it is also very important to be aware of this presentation as the treatment of this Brugada Phenocopy is different from ...
Satyajit Singh   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy